Starting
Initialising…
0%
BMPR1A
Final classification
VUS
BMPR1A c.398A>G · p.Tyr133Cys
BMPR1A

NM_004329.3:c.398A>G (p.Tyr133Cys) is a missense variant in exon 6 of BMPR1A, a gene in which pathogenic variants cause juvenile polyposis syndrome and are associated with hereditary colorectal cancer.

Gene
BMPR1A
Transcript
NM_004329.3
HGVS · transcript:coding
NM_004329.3:c.398A>G
Consequence
N/A
GRCh38
chr10:86899858 A>G
GRCh37
chr10:88659615 A>G
Basis gene-specific framework lacked a usable explicit final combination framework, so generic ACMG/AMP 2015 final-combination rules were applied as fallback; applied criteria: PM2 supporting; combination = 1 supporting, which maps to VUS.
gene-specific framework lacked a usable explicit final combination framework, so generic ACMG/AMP 2015 final-combination rules were applied as fallback; applied criteria: PM2 supporting; combination = 1 supporting, which maps to VUS.
Classification rationale
PM2 VUS
BMPR1A c.398A>G

NM_004329.3:c.398A>G (p.Tyr133Cys) is a missense variant in exon 6 of BMPR1A, a gene in which pathogenic variants cause juvenile polyposis syndrome and are associated with hereditary colorectal cancer. This variant is absent from gnomAD v2.1 and v4.1 population databases, meeting PM2 (supporting) for rarity.1 REVEL in silico prediction (0.623) is moderately elevated, but BayesDel (0.073) and SpliceAI (max delta 0.00) do not agree with a deleterious interpretation; PP3 is not met.2 The ClinVar entry (Variation ID 824461) is classified as Uncertain Significance by a single clinical laboratory (Ambry Genetics); no reputable source has classified this variant as pathogenic or benign.3 No functional studies, de novo reports, cosegregation data, or case-control studies were identified for this specific variant. The only criterion met is PM2 (supporting); no pathogenic or benign criteria of higher strength are satisfied. Overall, the evidence is insufficient to classify this variant above or below VUS under the generic ACMG/AMP 2015 framework.4

PM2 VUS
2 revelbayesdelspliceai ↗
4 generic_acmg_combination_rules
Gene diagram · NM_004329.3 · variants mapped to exon structure
BMPR1A NM_004329.3
Fetching transcript structure from UCSC…
Applied criteria · 1 met · select any tile
Met
Not met
Not assessed
N/A
Strength very strong supporting
Pathogenic evidence
PVS
PS
PM
PP
Benign evidence
BA
BS
BP
Rationale
Select a criterion.
Sources
Evidence used
    Gaps remaining
      Rule
      Research & evidence
      Population frequency
      gnomAD v4.1 screenshot
      gnomAD v4.1
      gnomAD v2.1 screenshot
      gnomAD v2.1
      Population frequency
      Absent from gnomAD v4.1.
      Absent from gnomAD v2.1.
      This variant is absent from gnomAD-Canada.
      ClinVar screenshot
      ClinVar
      This variant has been reported in ClinVar as Uncertain significance (1 clinical laboratory). (ClinVarID = 824461)
      SpliceAI screenshot
      In silico
      SpliceAI predicts no significant splice impact for this variant (max delta score = 0.00). REVEL score = 0.623. BayesDel score = 0.0733129.
      Functional / OncoKB screenshot
      Functional Unknown Oncogenic Effect
      OncoKB did not identify variant-specific reviewed functional evidence for this variant; gene-level curated context is available for reviewer follow-up. BMPR1A, a transmembrane receptor kinase, is frequently altered by mutation and deletion in various cancers, including colorectal and endometrial cance
      OncoKB ↗
      COSMIC screenshot
      COSMIC
      Cancer hotspots screenshot
      Cancer hotspots
      Somatic evidence Not in COSMIC / hotspots
      COSMIC
      This variant does not lie in a statistically significant hotspot. This variant has not previously been reported in somatic cancers (COSMIC).
      Hotspots
      This variant does not lie in a statistically significant hotspot.
      Literature · 1 PMIDs triaged · 1 high-priority
      1papers screened
      Papers triaged by theme: functional/splicing/segregation/case_observation. high_priority_papers include abstract snippets. Use these to support PS3/BS3/PS4/PP1/PP3/PP5.
      25394175 ↗ case observation
      A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment.
      The practice guidelines of the American College of Medical Genetics and Genomics (ACMG) and the National Society of Genetic Counselors (NSGC) are developed by members of the ACMG and NSGC to assist medical geneticists, genetic counselors, and other health-care providers in making decisions about appropriate management of genetic concerns, including access to and/or delivery of services. Each pract
      PP5PS4
      Sources & reference links
      7Sources
      ClinVar
      gnomAD v2.1
      gnomAD v4.1
      SpliceAI
      OncoKB
      COSMIC
      Cancer hotspots